Top Markets
#1 DogBull DogBull +36.28%
#2 The Bitcoin Bull The Bitcoin Bull +30.25%
#3 Siacoin Siacoin +27.47%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Pons Pons +20.43%
#6 MarsCoin MarsCoin +18.55%
#7 Ontology Gas Ontology Gas +18.26%
#8 Cash Cat Cash Cat +17.41%
#9 Akedo Akedo +12.86%
#10 Cryptopia Cryptopia +11.07%
Coin of the day
DogBull DogBull
설정
언어
한국어
통화
USD
테마
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
주식 순위 #14759
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
주가
$2.35
시가총액
$394.12M
변동 (1일)
-1.07%
변동 (1년)
-64.75%
국가
TW
거래 Lumosa Therapeutics Co., Ltd. (6535)

카테고리

Healthcare
Lumosa Therapeutics Co., Ltd. (6535)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Lumosa Therapeutics Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Lumosa Therapeutics Co., Ltd.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.95 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.19 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.75 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
24.99 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH